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SERUM LEPTIN IN CHILDREN WITH INSULIN DEPENDANT
DIABETES IN RELATION TO OBISITY
A. N. Ali1, S. G. Samir1
1Basic Medical Sciences, National Research Center, Cairo,
Egypt
Introduction: leptin is an obese gene product, an adipocyte
derived hormone that signals the state of energy stors to the brain
acting through specific receptorsin the hypothalamus(1). leptin
plays a crucial role in metabolic homeostasis by reducing feeding
behavior(2,3).to investigate wheather leptin concentratio in chil-
dren with type 1 diabetes was related to metaolic control, body
mass index or insulin, serum leptin, serum insulin and insulin-like
growth factor-1 levels were estimated in 30 diabetic non obese
children and 15 diabetic obese children and 15 lean children as
control.
Methods: serum leptin, serum insulin and insulin like growth
factor-1 were estimated by ELISE technique.Anthropometric
measures,were taken, boy mass index was calculated.
Results: serum of diabetic children either obese or non obese
had significantly higher levels of leptin and insulin copared with
lean control (P<0.001)and p<0,005 respectly).serum leptin level
was significantly correlated with body mass index (BMI) for the
combined group (dabetic obese and non obese and lean, r=.055,
p<0.01).
Table 1: Charactristics of IDDM non obese, IDDM obese and
lean children
age in years
IDDM non obese no=30
mean=8.43 SD=1.59
IDDM obese no.=15
mean=8.27 SD=1.83
lean control no.=15
mean=7.27 SD=1.87
sex (M:F) 16:14 8:7 6:9
height (cm) mean=129.27 SD=9.38 mean=124.67 SD=10.55 mean=117.33 SD=9
weight (Kg) mean=27 SD=5.99 mean=40 SD=10.28 mean=21.57 SD=4.49
BMI (Kg/m) mean=10.24 SD=1.98 mean=15.89 SD=3.31 mean=9.11 SD=1.21
duration of disease mean=3 year SD=1.58 mean=3.1 SD=1.8 ———
daily insulin U/day 39.1 SD=7.6 mean=52.93 SD=17.03 ———
none
Conclusion: the chronic increase in serum insulin levelin in-
sulin dependant diabetes mellitus children may be the cause of
elevated serum leptin in these children. not only BMI but also
insulin wee considered as significant pridictors of serum leptin
cocentration. insulin, therefor, might plays a major. role inserum
leptin concentration independant of obesity.
Reference(S): 1-Frederich R.c, Hamman A., Andrson S.,
LollmanB., LowellBB., Flier JS.leptin levels reflect body lipid con-
tent in mice. evedence for diet induced resistance to leptin action.
nature Medicine. 1995:1,1311.
2-mauzaki H, Ogawa Y , Isse N et al. Humman obese gene
expression. Diabetes, 1995:44:855.
3-camfield LA., SmithFJ., Gusez Y., et al. Recombinant
mouse ob protein: evidence for a propheral signal linking adipos-
ity toand central neural networks. science. 1995;269:546.
Submitted by: nadododo@yahoo.com
P1194
DIAGNOSIS AND MANAGEMENT OF BILIARY ATRESIA:
THE KAOHSIUNG EXPERIENCE
M. M. Tiao1, C. L. Chen2, Y. S. Chen2, P. P. Liu2, C. C.
Wang2, S. H. Wang2, Y. F. Cheng3, Y. J. Jong4
1Pediatrics, 2Surgery, 3Radiology, Chang Gung Memorial
Hospital, 4Pediatrics, Kaohsiung Medical University, Kaohsiung,
Taiwan
Introduction: To have a better understanding the character
and the current management of the biliary atresia.
Methods: One hundred and thirty one patients were reviewed
from charts with the diagnosis of biliary atresia. One hundred and
thirty cases, sixty-six males and sixty-five females, were in-
cluded.
Results: GGT/GOT was more than 2 in 78.5%, GGT/GPT in
83.4%, while 100% cases had alkaline phosphatase/GPT more
than 2. Type I in 13 cases (9.9%), type II in 10 cases (7.6%), type
III in 108 cases (82.4%), no expired cases were found in type I
and type II. Choledochal cyst was found in 10 cases (7.6%).
Combined with CMV infection was in 7 cases (5.3%), urinary tract
infection diagnosed in 23 cases (17.5%, E. coli in 11). Sixty-five
cases received portoenterostomy before 60 days old, 9 (13.8%)
was jaundice free. Portoenterostomy after 60 days old was 4
cases (7.8%) jaundice free, after 90 days old there were no cases
jaundice-free. Transplantation was indicated in the cases due to
the characterization of worsening cholestasis, which led to portal
hypertension and a decline in hepatic synthetic function. The age
of receiving transplantation was from 6-month-20-day to 9-year-
4-month old. The 1-year survival rate in portoenterostomy was
85.2%, 2-year 80%. Living donor liver transplantation 1-year sur-
vival rate was 97.1%, 2- years 96.4%.
Conclusion: Urinary tract infection should be checked in bil-
iary atresia cases. Portoenterostomy, after 90 days old, has a
poor jaundice free outcome. Liver transplanation, in the pediatric
population, especially living related offers improved survival and
quality of life.
Reference(S): 1.Howard ER, Tan KC: Br J Hosp Med 41:123,
1989
2. Martinez-Ibanez V, Bois-Ochoa J, Lloret J, et al: J Pediatr
Surg 27:830, 1992
3. Vacanti J, Shamberger R, Erakalis A, et al: J Pediatr Surg
25:149, 1990.
4. Mckiernan PJ, Baker AJ, Kelly DA: Lancet 355:25, 2000
5. Silveira TR, Salzano FM, Howard ER, et al: Acta Paediatr
Scand 80:1192, 1996
6. Vo Thi Diem H, Evrard V, Tran Vinh H, et al: Transplanta-
tion 75:1692, 2003
7. Al-Bassas A: Saudi Med J 24:S55, 2003
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ADVERSE EFFECTS OF FASTING THE PRETERM
E. M. AL-HADY1
1Pediatrics, Zagazig Univ., Egypt & Dr. Soliman Fkeeh Hosp.,
Jeddah, Saudi Arabia, & Int. Mem. of NASPAGHAN, Jeddah,
Saudi Arabia
Introduction: This article discusses the controversy of fluid
restriction and fasting of newborn & preterm versus fluid replen-
ishment and early feeding which has persisted even to the pre-
sent time. Thus, a brief history for this controversy is presented.
Methods: It has been found, through my work and observa-
tions in Neonatal Intensive Care Unit (NICU) over the last 20
years, that fasting the preterm led to many adverse effects. They
have been divided into:
Results: A) Immediate Effects (or in the first 3 days):
(I) HYPOGLYCEMIA
(II) DEHYDRATION & electrolyte imbalance
(III) HYPERBILIRUBINEMIA
(IV) HYPOCALCEMIA & occasional associated HYPOMAG-
NESEMIA
B) Late adverse effects:
1) HYPERBILIRUBINEMIA
2) HYPOPROTINEMIA
3) LOSS OF FAT
4) LOSS OF CALORIES („’CHO)
5) HYPOVITAMINOSIS
6) COMPLICATIONS OF TOTAL PARENTERAL NUTRITION
(TPN)
7) ANEMIAS OF PREMATURITY
During their discussion; my experiences, efforts and guide lines
in the management of (NICU) have been illustrated also.
Conclusion: Early feeding of the preterm - either by fluids or
milk - is advised to avoid all the above adverse effects.
Early enteral feeding - preferably by breast milk if possible - is
better than parenteral feeding , but guided by the general condi-
tion of the baby and the occurance of necrotising enterocolitis.
If breast milk suckling or expressed breast milk are not avail-
able or allowed , early preterm milk formula is advised.
Submitted by: prof_e_al_hady@doctor.com
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PANCREATITIS IN CHILDREN: A 10-YEAR ANALYSIS
C. Chen1, M. Kong1, H. Chao1, M. Lai1, C. Wang2
1Pediatric Gastroenterology, 2Radiology, Chang Gung
Memorial Hospital, Taoyuan, Taiwan
Introduction: Acute pancreatitis runs an unpredictable
courses. The etiologies, clinical presentations and outcomes are
different in children and adults. However, there has no reliable
prognostic factor been reported in children’s pancreatitis.
Methods: The medical records of 75 patients admitted due to
pancreatitis from July 1992 to June 2002 were reviewed retro-
spectively. The diagnosis of pancreatitis was based on clinical
symptoms, elevation of at least threefold of normal upper limit of
pancreatic enzymes, and image findings. Data analyses were
performed employing the Fisher’s exact test for nominal vari-
ables, and nonparametric test for continuous variables.
Results: This study comprised 75 patients, including 37
males and 38 females, with 96 episodes of pancreatitis. The
mean age was 10.1 ± 4.6 years (range 2 to 18 years). There were
20 patients with unknown etiology (26.7%); 15 with biliary dis-
ease (20.0%); 13 with abdominal trauma (17.3%).
The common clinical symptoms included abdominal pain
(93.8%), vomiting (64.2%), and fever (33.3%). 55 patients were
managed conservatively, while the other 20 patients (26.7%) re-
ceived surgical or other interventional treatment. 13 of them
(65%) were associated with biliary tract diseases, 4 (20%) with
abdominal trauma, and 3 (15%) with peritonitis.
In 85 episodes of non-traumatic pancreatitis, 17 episodes
(20%) were severe pancreatitis. Among these patients, 12 had
organ failure, DIC or metabolic disturbances, and the other 5 had
local complications. 4 patients died of the disease. The mortality
rate was 5.3%.
We compared initial clinical symptoms, laboratory param-
eters, and CT severity index between severe and mild pancre-
atitis. In severe patients, plasma AST, BUN, LDH and CRP level
increased, while albumin and calcium levels decreased signifi-
cantly. The Balthazar CT severity index (CTSI) >5 significantly
correlated with severe pancreatitis (p=0.03), and CTSI>6 signifi-
cantly correlated with death (p=0.03).
Conclusion: The overall outcomes of children’s pancreatitis
are good, but some of them developed severe disease and may
require surgical intervention. CTSI is an applicable and compa-
rable predictor for severe outcomes in children’s pancreatitis.
Reference(S): 1. Yeung CY, et al. Pancreatitis in children-
experience with 43 cases. Eur J Pediatr1996; 155:458–463
2. Simchuk, et al. Computed Tomography Severity Index Is a
Predictor of Outcomes for Severe Pancreatitis. Am J Surg 2000;
179:352–5
3. Chatzicostas, et al. Balthazar Computed Tomography Se-
verity Index Is Superior to Ranson Criteria and APACHE II and III
Scoring Systems in Predicting Acute Pancreatitis Outcome. J
Clin Gastroenterol 2003; 36:253–260
Submitted by: wincarol@adm.cgmh.org.tw
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IMMUNE RESPONSES IN VITRO TO THE HLA CLASS
I-RESTRICTED A-GLIADIN PEPTIDE 123–132 (PEP A2) IN
CULTURES OF INTESTINAL MUCOSA FROM COELIAC
DISEASE PATIENTS ON GLUTEN-FREE DIET
G. Mazzarella1, C. Gianfrani1, R. Stefanile1, V. Salvati2, N.
Giardullo3, G. Iaquinto4, C. Faruolo5, E. Cosentini6, R.
Troncone2, S. Auricchio2, A. Sette7
1Institute of Food Science and Technology, National Council
Research, Avellino, 2Paediatrics and ELFID, University
Federico II, Naples, Italy, 3Gastroenterology, S Giuseppe
Moscati Hospital, 4Gastroenterology, S Giuseppe Moscati
Hospital,, 5Institute of Food Science and Technology, National
Council Research, Avellino, , 6 Immunohematology, University
Federico II, Naples, Italy, 7Allergy and Immunolgy, La Jolla,
San Diego, CA, United States
Introduction: Coeliac disease (CD) is associated with HLA
class II-restricted CD4+ T mediated gliadin-specific responses,
albeit a massive infiltration by CD8+ T cells represents the dis-
ease hallmark. A 10mer gliadin peptide (A-gliadin 123–132) is
recognized by class I-restricted CD8+ T lymphocytes from both
peripheral blood and intestinal mucosa of HLA-A2+ CD patients
(1). We have tested in the organ culture of treated coeliac mu-
cosa the capacity of A-gliadin 123–132 peptide to activate the
local immune response.
Methods: Jejunal biopsies were obtained from 11 treated
coeliac patients (6 HLA-A2 positive and 5 HLA-A2 negative), and
in vitro cultured for 24 hours with A-gliadin 123–132 QLIPCMD-
VVL (pep A2). A peptic-tryptic digest of gliadin (PT-gliadin), or the
immunodominant, A2-restricted, HIVgag 17 peptide SLYNTVATL
(pep C), were used as controls. Immunohistochemical analysis
was carried out assessing lamina propria CD25+ cells, IEL CD3+
cells density and FAS epithelial expression. Percentage of
CD8/CD25, CD8/CD69, CD8/FAS-L double positive cells were
evaluated by FACS analysis on cells isolated from two different
CD biopsies cultured with medium or pep A2.
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Results: In HLA A2+ coeliacs lamina propria CD25+ cells in
biopsies cultured in the presence of pep A2 (median, range: 95,
38–107) or PT (122, 58–213), were significantly higher (p<0.05)
than in biopsies cultured with medium alone (27, 18–48) or pep C
(27, 15–39). Similarly, the density of IEL CD3+/mm epithelium
was higher for pep A2 and PT (42, 27–48; and 50, 39–71 vs
medium: 28, 18–55 or pep C: 26, 23–28). Increased FAS epithe-
lial expression was also noted. No differences were observed
with pep A2 compared to medium in cultures of HLA A2- biopsies.
An enhanced frequency of CD8/CD25 and CD8/FAS-L double
positive cells was observed in cell preparations from pep A2-
cultured biopsies compared to medium-cultured biopsies.
Conclusion: These data show that pep A2 is able to activate
a peptide specific-immune response in HLA-A2+ coeliac patients
and suggest the involvement of mucosa infiltrating CD8 T lym-
phocytes in CD pathogenesis. This work underlines also the im-
portance of in vitro organ culture as a valuable tool to test the
toxicity of gliadin peptides for coeliac patients.
Reference(S): 1. Gianfrani et al J Immunol. 2003;170:2719).
Submitted by: gmazzarella@isa.cnr.it
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WILSON’S DISEASE IN CHILDHOOD - PRESENTATION
AND MANAGEMENT (4 YEARS RETROSPECTIVE STUDY)
A. Constantinescu1, S. Boroghina1, C. Arion1
1Pediatric Department, Fundeni Clinical Institute, Bucharest,
Romania
Introduction: Objective of the study:to evaluate the effective-
ness of different treatments methods with chelating agents,Zinc
or Orthopic Liver Transplantation,based on hepatic or neurologi-
cal manifestation at the pediatric patients with Wilson’s Disease.
Methods: Between January 2000 and December 2003 14
children were Wilson’s Disease diagnosed:10 male and 4 female,
with an average age of 10,2 years.The average duration from the
beginning to the diagnosis was 14 months,longer at those ones
with initial neurological disorder (20 months).The diagnosis was
based on the low serum ceruloplasmin level (under 0,2g/l), in-
creased of the copper in 24-hours urine and the presence of
Kayser-Fleischer rings.The chelating drugs D-Penicillamine was
the main stay of therapy for 10 patients (2 of them in association
with Zinc); only 1 patient was treated with Zinc salts,one with
Trientine and 2 benefited by Orthotopic Liver Transplantation. No
severe side effects were noticed.We have regularly monitories
(every 6 months):serum copper,ceruloplasmin,liver biochemis-
tries and physical examination.We measured the copper excre-
tion in 24-hours urine (under 0,5mg/l)every 6 months.
Results: All patients had a hepatic disease at the beginning
of the study:hepatic cirrhosis (6 cases),chronic hepatitis(3), ful-
minate hepatic failure(3). 5 patients had a neuropsychiatrical dis-
order.2 patients with fulminate hepatic failure and hemolytic ane-
mia who benefited by Orthotopic Liver Transplantation had a
good further evolution.A patient with fulminate hepatic failure was
treated with Trientine during a month,without improvement and
evolution to exitus-we suspect poor compliance at the treatmen-
t.At the 5 patients with hepatic and neurological manifestation a
partial remition of the neurological symptoms was achieved and
the hepatic disease was stabilized.The neurological improvement
was faster at those who received Zinc as well.At the 6 patients
with hepatic disease, treated with D-Penicillamine a hepatic func-
tion improvement was noticed (3 by those ones were at presymp-
tomatic stage).
Conclusion: 1. The liver disease (unknown origin) with posi-
tive family history should imply Wilson’s Disease strongly.
2. The faster the introduction of the chelating therapy is, the
better the results are.
3. At the symptomatic patients with a good compliance at the
treatment an improvement of the hepatic disease was obtained.
4. The patients at whom the chelating treatment was initiated
before the beginning of the clinical symptoms had an excellent
evolution: no appearance of the symptoms on the followed pe-
riod.
5. For patients with fulminate hepatic failure and hemolytic
anemia the only solution was the Orthotopic Liver Transplanta-
tion.
Submitted by: nicolae_boroghina@goodyear.com
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RECRUITMENT AND ACTIVATION OF DENDRITIC CELLS
BY HELICOBACTER PYLORI
S. J. Czinn1, T. Blanchard1, K. Anderson1
1Division of Pediatric Gastroenterology, Rainbow Babies and
Children’s Hospital, Cleveland, United States
Introduction: The means by which lymphocytes become ac-
tivated in the gastric mucosa during H. pylori infection have not
been described. Several different antigen presenting cell (APC)
types may play a role in T cell activation including dendritic cells,
macrophages, and epithelial cells. The aim of this study was to
characterize and compare the phenotypes of these APCs follow-
ing in vitro stimulation with H. pylori.
Methods: For immunofluorescence, frozen sections of gastric
tissue were prepared from infected and naı¨ve mice, and stained
with labeled antibody specific for cell markers, and DAPI. The
murine gastric epithelial cell line GSM06, freshly isolated perito-
neal murine macrophages, and murine bone marrow derived
dendritic cells were tested for activation in vitro. Dendritc cells
were derived by culture of freshly isolated bone marrow cells in
the presence of 10 ng/ml GM-CSF for 5 days, and then purified
by positive selection for CD11c-positive cells. Purified dendritic,
or the other cell types listed above, were then incubated for 48
hours in the presence of H. pylori SS bacteria, H. pylori antigen,
or without stimulation. Supernatants were removed for cytokine
analysis by multianalyte profiling and ELISA, and the cells were
prepared for flow cytometry analysis using antibodies specific for
CD80, CD86 or MHC Class II (I-Ab).
Results: CD11c-positive dendritic cells were prevalent in the
gastric mucosa of infected mice compared to naı¨ve mice. In cul-
ture, stimulation of dendritic cells resulted in morphologic
changes including the development of dendrites. Stimulation of
GSM06 cells resulted in marginal increases of inflammatory me-
diators but both macrophages and dendritic cells produced sig-
nificantly higher amounts of IL-12, TNF±, and MIP-2, with the
greatest increases observed for KC and IL-6. Flow cytometry
analysis demonstrated that unstimulated dendritic cells displayed
a higher percentage of positive cells for CD80, CD86 and MHC II
than unstimulated macrophages. Stimulation with H. pylori re-
sulted in increased, and ultimately equivalent expression of CD86
and MHC II on both dendritic cells and macrophages. However,
CD80 expression of macrophages remained below 10%, even
after stimulation, whereas dendritic cells increased expression
14% following stimulation to 46% positive cells.
Conclusion: Dendritic cells are present in the Helicobacter-
infected gastric mucosa, and responsive to H. pylori stimulation in
vitro. T cell stimulatory markers and cytokine expression indicate
that dendritic cells may be a primary APC for immune induction
during H. pylori infection.
Submitted by: sjc3@cwru.edu
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EFFICACY OF COMBINATION PROPHYLAXIS WITH
SHOURT-TERM HBIG AND LONG-TERM LAMIVUDINE IN
PREVENTING DE NOVO HEPATITIS B INFECTION IN
CHILDREN
S. Y. Lee1, S. Chang1, B. Choi1, K. Kim1, S. Hwang2, K. Park2,
Y. Lee2, S. Lee2
1Department of Pediatrics, 2Department of Surgery, University
of Ulsan College of Medicine, Asan medical center, Seoul,
South Korea
Introduction: We performed current study to evaluate the
incidence of de novo HBV infection after liver transplantation ac-
cording to the donor status of HBcAb and the efficacy of prophy-
laxis.
Methods: Non-concurrent comparative study was done in 61
children who received liver transplantation at Asan Medical Cen-
ter from 1994 to 2001. We compared the incidence of de novo
HBV infection according to the status of the donor HBcAb and
analyzed the efficacy of prophylaxis. Lamivudine was adminis-
tered at a dose of 2 mg/kg indefinitely. HBIG was administered
under a standard protocol (100 IU/kg qd ×7 days, then keep the
titer of HBsAb > 100 mIU/mL for the first 6 months then stopped).
Results: All of 61 donors and recipients were HBsAg and
HBV DNA negative preoperatively. Twenty seven (44%) of 61
were HBcAb positive and 17 of them received prophylaxis. While
de novo HBV infection did not occur in 34 children with HBcAb
negative donor, those in 10 children with HBcAb positive donor
without prophylaxis developed in 4 children (40%). De novo HBV
infection was not occurred among 17 children with prophylaxis.
Outcomes of 4 children with de novo HBV infection with lamivu-
dine therapy were disappearance of HBsAg in 1, negative sero-
conversion of HBeAg in 1, and persistence of HBeAg in 2 children
respectively.
Conclusion: HBcAb positive donor is associated with de
novo HBV infection. Short-term HBIG and long-term lamivudine
prophylaxis suggests to be effective in preventing de novo HBV
infection in HBcAb positive donor graft.
Submitted by: xione@hanmail.net
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CHOLESTEROL ESTERS DISEASE..2 CASES REPORT
R. Cervantes-Bustamante1, M. Fernandez Aragon1, J. A.
Ramirez Mayans1, B. De Leon Bojorge2, F. Zarate
Mondragon1, N. Mata Rivera1, M. Garcia Campos1
1Gastroenterology and Nutrition, 2Pathology Departmen,
Instituto Nacional de Pediatria S.S., Me`xico City, Mexico
Introduction: Cholesterol esters disease (ENEC), is a lipid
metabolism autosomic recesive disease, due to acid lipase liso-
somal (ALL) deficiency, a glycoprotein which hydrolyzes choles-
terol esters and triglycerides in order to be used by cells; these
molecules are deposited in different organs such as liver, spleen,
small bowel, lymphatic nodules, suprarenal glands.
Methods: Case 1: 3 years old female. Who has initiated
symptoms a year before with vomit, diarrhea, hiporexia, liver and
spleen enlargement. Weight 11.6 kg, Height 82 cm. Liver was
soft and smooth by palpation to 8 cm below costal edge, by total
percussion 12 cm which cross medium line; spleen enlargement
4 cm. CBC: Hb 12.9, PMN 18,000, platelets 661,000. Glycemia
77, creatinine 0.3, AST 178, ALT 56, DHL 252, AP 271, GGT 62,
TB 0.58, cholesterol 335, triglycerides 273. Ultrasonography
study: liver and spleen enlargement with increase of echo-
genicity. Endoscopy: showed edema and the presence of velvet
yellow appearance from the duodenal bulb up to third portion.
Duodenal biopsy: lamina propia partially infiltrated by granular
and foamy macrophages. Liver biopsy: portal and pericelular fi-
brosis with granular and foamy macrophages. Case 2: 4 years
old male. Who has initiated symptoms a year before with pale,
vomit, weight loss, hiporexia, liver and spleen enlargement.
Weight 13.5 kg, Height 94 cm. Liver was soft and smooth by
palpation to 8 cm below costal edge, by total percussion 12.5 cm
which cross medium line; spleen enlargement 4 cm. CBC: Hb
5.1, PMN 4,700, platelets 447,000. Glycemia 92, creatinine 0.25,
AST 96, ALT 38, AP 158, GGT 59, cholesterol 266, triglycerides
258. Ultrasonography study: liver and spleen enlargement with
normal echogenicity. Endoscopy: showed edema and the pres-
ence of velvet yellow appearance from the duodenal bulb up to
third portion. Duodenal biopsy: lamina propia partially infiltrated
by granular and foamy macrophages. Liver biopsy: small drops
steatosis, portal and pericelular fibrosis with granular and foamy
macrophages. Electronic microscopy: confirmed lipidic infiltra-
tion. Discussion: Both patients show by endoscopy lipidic depos-
its in small bowel; and the liver biopsy steatosis and granular and
foamy macrophages. These findings confirmed the diagnosis.
Results: Both patients show by endoscopy lipidic deposits in
small bowel; and the liver biopsy steatosis and granular and
foamy macrophages. These findings confirmed the diagnosis.
Conclusion: Inborn errors of lipid metabolism should be con-
sider in preschool children with hepato-splenomegaly and el-
evated serum cholesterol and triglycerides.
Submitted by: robertocervantesb@yahoo.com.mx
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THE PHARMACOKINETICS (PK) AND SAFETY OF A
SINGLE DOSE OF ADEFOVIR DIPIVOXIL (ADV) IN
CHILDREN AND ADOLESCENTS (AGED 2–17) WITH
CHRONIC HEPATITIS B
E. Sokal1, D. Kelly2, S. Wirth3, J. Mizerski4, B. Lu5, K. Kleber5,
J. Shah5, G. Currie5, C. L. Brosgart5
1Pediatrie, Cliniques Universitaries, Saint- Luc, Bruxelles,
Belgium, 2Children’s Hospital, University of Birmingham,
Birmingham, United Kingdom, 3Zentrum fu¨r Kinder, - und
Jugendmedizin der Klinikum Wuppertal GmbH, Wuppertal,
Germany, 4Oddzial Choro´b Infekcyjnych Dzieci, Krakowski
Szpital Specjalistyczny im, Jana Pawla II, Krako´w, Poland,
5Clinical Research, Gilead Sciences, Inc., Foster City, CA,
United States
Introduction: ADV 10 mg is approved for the treatment of
chronic hepatitis B (CHB) in adults. ADV as a 10 mg tablet and an
oral suspension is in development for the treatment of CHB in
pediatrics. The objective of this study was to evaluate the PK of
adefovir in pediatrics and established dosing guidelines for pa-
tients aged 2–17 years.
Methods: Forty-seven HBeAg+ CHB patients with serum
HBV DNA log10 copies/mL (Roche Amplicor MonitorTM; PCR),
and ALT  2xULN were enrolled in the study. Subjects 2–11
years received single doses of 0.14 mg/kg and 0.3 mg/kg (ap-
proximately 2× adult dose) in a cross over design with a 7-day
washout period. Subjects 12–17 years received a single dose of
10 mg ADV. Following each dose, ADV levels were assessed at:
0, 0.5, 1, 2, 4, 6, 8, 12 and 24 hours post dose.
Results: Forty-five subjects were dosed. PK parameters of
adefovir in subjects  12 years were similar to those seen in
adults (Cmax =17.47 ng/mL and AUCinf. =210.15 ng*hr/mL). In
subjects 2–6 and 7–11 years, a dose of 0.14 mg/kg resulted in
relative underexposure; 0.3 mg/kg resulted in a higher Cmax but a
comparable AUCinf. to adults. PK modeling was performed to
identify a suitable dose for each age group. No clinically signifi-
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cant adverse events were observed except one SAE unrelated to
treatment.
Table 1: Age group and dose
2–6 2–6 7–11 7–11 12–17
n=12 n=12 n=18 n=18 n=15
0.14 mg/kg 0.3 mg/kg 0.14 mg/kg 0.3 mg/kg 10 mg
AUC inf. [ng*/mL] 104.74±33.76 224.13±78.72 128.48±53.81 292.44±105.08 237.30±56.96
Cmax [ng/mL] 14.48±5.27 26.93±7.86 14.12±4.61 33.25±8.77 22.75±4.62
Clast [ng/mL] 2.35±1.06 2.40±0.98 1.78±0.62 2.71±1.16 2.70±1.03
Conclusion: Based on this PK data, the proposed pediatric
dose for phase 3 studies is 0.3 mg/kg for patients 2–6, 0.25
mg/kg for patients 7–11 and 10 mg for patients 12–17 years of
age, with a maximum total dose of 10 mg daily, to achieve the
target exposure or AUC of adefovir similar to the adult 10 mg
dose. ADV was well tolerated at all doses.
Submitted by: Charmaine.Glenn@gilead.com
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TREATMENT WITH THALIDOMIDE IN CHILDREN AND
ADOLESCENT WITH INFLAMMATORY BOWEL DISEASE
(IBD)
S. Martelossi1, T. Gerarduzzi1, F. Marchetti1, A. Lenhardt1, I.
Giuseppin1, M. Lazzerini1, E. Barbi1, G. Di Leo1, A. Ventura1
1Department of Pediatrics, per l’Infanzia Burlo Garofolo,
Trieste, Italy
Introduction: several small studies have evaluated the role
of thalidomide in adults with refractory CD, but limited experience
is available in pediatric population with IBD.
Aim: to assess the efficacy and the safety of low dose tha-
lidomide in pediatric and adolescent patients with IBD, intolerant
or refractory to conventional medical treatment.
Methods: we selected 23 patients (16 affected by CD and 7
by UC) steroid-dependent and refractory to either azathioprine or
cyclosporine over 167 IBD patients (13.7%; CD, n=77; UC, n=69;
indeterminate colitis, n=14) followed in our Pediatric Department.
They received thalidomide 0.5–2 mg/kg/day orally and their re-
sponse was assessed according to clinical score, colonoscopy,
histological score and immunological methods.
Results: the mean age at IBD diagnosis was 10 y (range
1–17y). The mean duration of treatment with thalidomide was
20.6 moths (range 1–63m). Eighteen over 23 patients (78%;
CD=14/16, 87%; UC=4/7, 57%) had a significant clinical re-
sponse, while 5/23 (3 with UC and 2 with CD) did not respond.
The mean Pediatric Crohn Disease Activity Index decreased from
37.5 to 7. Steroid treatment was tapered and then discontinued in
16 patients within 1–3 months. Endoscopic and histological in-
flammation, C-protein and erythrocyte sedimentation rate (ERS)
all decreased significantly. In one adolescent , thalidomide was
effective in maintaining the infliximab-induced remission, allowing
us to spare multiple infusions. Two patients affected by UC un-
derwent surgery and stopped treatment. Side effects with the low
dose thalidomide used were mild and mostly transient: sedation,
dermatitis, drowsiness. Peripheral neuropathy occurred in 3 pa-
tients: the first one developed neuropathy after 5 years of treat-
ment, then stopped thalidomide maintaining remission (follow-up
after withdrawal of 2 years); the second one is still taking thalido-
mide because of good clinical response and the distal sensorial
neuropathy is kept under control by administration of vitamin B12
and carnitine; the third one developed neuropathy after one
month of treatment, then stopped thalidomide without any im-
provement of the intestinal symptoms.
Conclusion: our not controlled clinical study showed that tha-
lidomide is well tolerated and effective in pediatric and adolescent
IBD patients. Experiences with thalidomide in cases of refractory
IBD are very limited and the results of the first observational
studies are very encouraging. Comparative studies are needed to
define the therapeutic role of thalidomide in respect to other
drugs such as infliximab, azathioprine and methotrexate
Submitted by: martelossi@burlo.trieste.it
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TO BE ILL AS NARRATED BY CHILDREN 11–18 YEARS
M. Forsner1, J. Lilian2, V. Sorlie3
1University of Umea, Faculty of Medicine, Inst. of Clin. Science,
Pediatrics, University of Umea, 2University of Umea, Faculty of
Medicine, Inst. of Nursing, Umea, Sweden, 3University of Oslo,
Faculty of Medicine, Inst. of Nursing, Oslo, Norway
Introduction: The illness narrative can give professionals
and caretakers a shared understanding of illness. The child’s
perspective of illness is seldom obtained. The aim with the study
was to illuminate the experience of being temporarily ill at the age
of 11–18 years.
Methods: Four girls and one boy, 11- 18 years old with tem-
porarily illness were interviewed. They were acutely ill, injured, or
underwent planned surgery. The interview was an open conver-
sation and data was subjected to qualitative content analysis.
Results: To be ill was to be lost, lost in the body and lost in
the feelings. To be ill was to be hurt, the body hurt and the
children were hurt by others. To be ill was to be in need of com-
fort, comforting oneself and comforted by others.
Conclusion: To care for children at this age is to strike a
balance between meeting dependency and independence. Rou-
tines and expectations can hinder nurses from being close to the
children. The greatest task for professionals seems to be to meet
the children with respect in their experience.
Reference(S): Burnard, P. (1991) A method of analysing in-
terview transcripts in qualitative research. Nurse Education to-
day, 11, 461–466
Burnard, P. (1996) Teaching the analysis of textual data: an
experiential approach. Nurse Education today, 16; 278–281.
Riessman, C. K. (1993) Narrative analysis. Sage Publication,
Newbury Park
So¨rlie, V., Jansson, L. & Norberg, A. (2003) The meaning of
being in ethically difficult situations in paediatric care as narrated
by female registered nurses. Scandinavian Journal of Caring Sci-
ence, 17; 285–292.
Toombs, K.,S. (1992) The meaning of illness, A phenomeno-
logical account of the different perspective of physicians and pa-
tient. Kluwer Academic Publisher, Dordrecht
Woodgate, R. (2001) Adopting the qualitative paradigm to
understanding children’s perspectives of illness: barrier or facili-
tator? Journal of Pediatric Nursing 16; 149–161.
Submitted by: maria.forsner@vll.se
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RELATIONSHIP BETWEEN EARLY FEEDING AND
COMMUNICATION DEVELOPMENT IN INFANTS: BIRTH TO
12 MONTHS.
S. J. Massey1, K. M. Hird1, K. Simmer2
1Psychology, Curtin University of Technology, 2Neonatal
Paediatrics, King Edward Memorial Hospital, Perth, Australia
Introduction: Anecdotal reports suggest that infants experi-
encing early feeding difficulties may have delays in communica-
tion development
Methods: The first stage of the study involved the develop-
ment of a theoretically based assessment protocol to test the
POSTER SESSION ABSTRACTS 227
J Pediatr Gastroenterol Nutr, Vol. 39, No. 2, August 2004
hypothesis of linked or independent processes required for feed-
ing and speech. The assessment protocol will be piloted on 10 full
term and 10 preterm infants at birth, 4, 8 and 12 months post term
age. Measures of inter-judge and intra-judge reliability will also be
taken of the observation protocol. Observation of the infant’s lan-
guage, speech, environment and maternal relationship will also
be conducted to determine the nature and impact of environmen-
tal and social factors on feeding and/or speech and language
development.
Results: To be analysed
Conclusion: It is hypothesised that infants experiencing early
feeding difficulties and delay will also experience later speech
and language delay.
Reference(S): Blanchard, I. (1963). “Better feeding can mean
better speaking.” The American Journal of Nursing 63(11).
Carpendale, J. I. and C. Lewis (in press). “Constructing an
understanding of mind: the development of children’s social un-
derstanding within social interaction.” Behavioral and Brain Sci-
ences.
Mathisen, B., L. Worrall, et al. (2000). “Feeding problems and
dysphagia in six-month-old extremely low birth weight infants.”
Advances in Speech-Language Pathology 2(1): 9–17.
Starr, S. (2003). Facilitating early feeding and speech devel-
opment. Speech Pathology Australia, Northam.
Ziegler, W. (2003). “Speech motor control is task-specific: Evi-
dence from dysarthria and apraxia of speech.” Aphasiology
17(1): 3–36.
Ziegler, W. (2003). “To speak or not to speak: Distinctions
between speech and nonspeech motor control.” Aphasiology
17(2): 99–105.
Submitted by: s.massey@curtin.edu.au
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DEPRESSION OF WORKING NURSES’ IN EDUCATIONAL
UNIVERSITY HOSPITALS COMPARED WITH NURSING
EDUCATORS IN NURSING & MIDWIFERY SCHOOL OF
ISFAHAN UNIVERSITY OF MEDICAL SCIENCES
H. Farahmand1, M. Nasiri1
1Faculty of Nursing, Isfahan University, Iran
Introduction: Nursing is an occupation taking care of hu-
mans’ health. Nurses are targeted for depression due to numer-
ous reasons as high stress existing in hospitals, critical status of
the patients in pain arousing nurses’ sympathy and higher num-
ber of female nurses compared with male nurses. Since nursing
educators are in interaction with patients from one hand and with
patients and students from other hand and as depression can be
transferred from one to one, this study has tried to investigate
average depression as the most indirect and hardest one is all
above three groups.
Methods: This is a descriptive analytic cross sectional study.
Beck depression test was used to collect depression. The popu-
lation studied was composed of all nursing personnel including
staff nurses and nurse educators working in Isfahan medical uni-
versity hospitals with at least six months of work experience. The
samples were selected by quota sampling. The collected data
were analyzed by SPSS software with K- square test.
Results: The population studied included 395 working nurses
in hospitals and 64 nurse educators working in nursing & Mid-
wifery school with mean age of 33 .47±0 .4. There was no sig-
nificant difference between the level of depression among nurse
educators and working staff in hospitals there was more depres-
sion mentioned among single ones, females, staff on rotating
morning evening shifts, subjects aged between 26 to 34 years
and 1 to 5 years of experience, subjects with low job satisfaction,
low social class of the job, words such as operating room, cancer
and critical units and low income.
There was a significant association between depression level
and alternatives as working in shift, job satisfaction and the type
of word.
Conclusion: The following items look to promote the mood of
nurses if followed precisely:
1-Promotion of economic status
2-Disappearing the gap between theoretic and practical nurs-
ing
3-Providing hospitals with better facilities and technology
4-Making a more realistic suicide attitude toward nursing
5-Making physicians and other health staff acquainted with
the role of nursing
6-On time encouragement and introducing out standing
wards.
7-Making variation in working shifts for ward with higher risk of
depression
8-Allocating more days of off and better facilities for rest time.
9-Specifying hospital green space for personnel usage
10-Respecting the items of risk factors mentioned in findings
Submitted by: farahmand_2000@yahoo.com
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HELICOBACTER INFECTION IN CHILDREN
E. J. Soelaeman1, B. Purnomo1, Sukma1, W. Merati1, H. N.
Soehardjo1, H. S. Digdowirogo1
1Harapan Kita Children and Maternity Hospital, Jakarta,
Indonesia
Helicobacter Pylori (HP) in children causes some gastrointes-
tinal diseases i.e chronic gastritis or peptic ulcer. The symptoms
are Recurrent Abdominal Pain (RAP), dyspepsia, vomiting, he-
matemsis or anorexia. Most of our patients from previous study,
the cause of these symptoms is HP. Therefore, HP diagnosis in
children is important to make as early as possible and some
investigators suggested to treat the patients especially the pa-
tients with symptoms.
The aim of our study is to know the incidence of HP in our
populations, to report the symptoms of HP infection, the diagno-
sis of HP by endoscopic biopsy and the effect of HP treatment on
the patient’s symptoms.
Methodes: All patients with upper endoscopy included to this
study except patients with esophageal varices or corpus alienum.
Result: From July 2002 to November 2003, 62 patient were
included to the study. The average age is 5 years and 11 monts
(range from 1 months to 18 years). We found HP in 30 patients
our of 62 patients (48%). The symptoms are RAP in 19 out of 30
patients (63.3%), dyspepsia in 5 patients (16.7%), hematemesis
in 3 patients (10%) and anorexia in 3 patients (10%). Endoscopic
diagnoses are Gastroduodenitis in 12 patients, Esofagogastro-
duodenitis 5 patients, Esofagogastritis 5 patients and normal in 8
patients. Nodularity of duodenum were found in 8 patients
(26.7%). From histopathologic examination, we found HP at du-
odenum in 21 patients, Anthrum pyloric in 24 patients and corpus
in 9 patients. All patients were treated with triple therapy (Amoxy-
cillin, clarithromycine and omeperazole) for 7 days. The symp-
toms were relieved in 27 patients (90%). Three patients still have
RAP, which were cured after omeperazole administration for 2
weeks.
Conclusions:
1. HP incidence in our patients population is 48%
2. The most frequent symptom of HP infections in our patients
is RAP
3. The other symptoms are hematemesis, dyspepsia and an-
orexia
4. We found HP more frequent at anthrum pylori compared to
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duodenum and corpus gaster, but in 2 patients we only found HP
at corpus
5. The treatment was succeeding to relieved the symptoms in
most patients
Submitted by: idaf@jsx.co.id
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BILIARY ATRESIA IN INFANTS
E. J. Soelaeman1, T. A. Meliani1, B. Purnomo1, H. N.
Soehardjo1, H. S. Digdowirogo1
1Harapan Kita Children and Maternity Hospital, Jakarta,
Indonesia
Kasai operation is still the firstline treatment for bilary atresia
at our hospital. The aim of this study is to evaluate the outcome
of infants with Biliary atresia.
Method: Retrospective analysis of medical records of pa-
tients with biliary atresia from 1999 to 2002
Result: Sixteen patients were included to the study. The av-
erage age of presentation was 2 months (range 1 month to 18
months). Two patients were not underwent Kasai procedure due
to late diagnosis. Two patients were died immediately after the
procedure and 1 patients after 10 months follow up. Kasai op-
eration were perfomed in 9 patients during Golden age period. All
patients had portoenterostomy done.
Complications included cholangitis (55%), Portal hipertension
(75%) and hepatopulmonar syndrome (5%). The average time of
jaundice free after operation was 5 month (2–12 months). Time
for jaundice free was 3 months for patients who underwent Kasai
during golden age period and 5 months after the period (statisti-
cally signifant :p <0.05). The outcome of patients was related to
clearance of jaundice (p <0.05).
Conclusions: We still had Biliary atresia patients after 3
months old at the first presentation. Kasai procedure helps pa-
tients but it was important to have thisoperation before 12 weeks
old. Postoperative jaundice free can predict the outcome of our
patients.
Submitted by: idaf@jsx.co.id
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THE STUDY OF LONG-TERM EFFECTS OF MARGINAL
VITAMIN A DEFICIENCY DURING GESTATION AND TWO
GENERATIONS ON GROWTH AND METABOLIC INDICES
IN RAT.
Vafa MR, (Ph.D.); Taleban FA, (Ph.D.); Siasi F, (Ph.D.);
Kimiagar M, (Ph.D.); Mehrabi Y, (Ph.D.); Arjomand M, (Ph.D.)
Background: Long-term effects of malnutrition on growth and
metabolic indices are investigated in several case-control studies
but the effects of long-term marginal vitamin A deficiency have
not been studied yet.
Objective: In this regard a dietary study on growth and meta-
bolic indices was conducted in a rat model during gestation and
for two generations.
Methods: Firstly, seventeen pregnant rats were fed randomly
a vitamin A sufficient (VAS) and vitamin A marginal (VAM) diet,
from the first day of gestation until the last day of lactating their
pups. In the next stage from female offspring in VAM, 14 female
pups were fed randomly VAS (recovery group) or VAM diet.
Seven female pups in VAS (control group) were fed the same
diet. After mating and confirmation of pregnancy, feeding adult
animals the same diet continued in each group till termination of
lactation. This procedure continued until the puberty of second-
generation pups. Weight and height of all animals were recorded
at puberty. Furthermore, hematological parameters (serum reti-
nol, triglycerides, cholesterol and glucose) were studied in all
animals after termination of lactating period. Obtained data were
analyzed using ANOVA, Tukey, t-test, Mann-Whitney, Pearson
Correlation and analysis of regression tests.
Results: Our results indicate that marginal vitamin A defi-
ciency was accompanied with significant reduction in serum ret-
inol in VAM group compared to VAS and recovery groups
(P<0.001).
—Marginal vitamin A deficiency increased the serum triglyc-
eride in VAM and recovery groups compared to VAS group sig-
nificantly (P<0.01) and a negative significant correlation ob-
served between retinol and serum triglyceride in the first (R=0.53,
P<0.05) and the second generations (R=0.61, P<0.005).
—Marginal vitamin A deficiency increased the serum choles-
terol from the zero to the second generations in VAM group sig-
nificantly (P<0.001). Meanwhile serum cholesterol in recovery
group was increased from the first to the second generations
(P<0.01). And a significant quadratic correlation observed be-
tween retinol and serum cholesterol in the second generation
(R=0.77, P<0.001).
—Marginal vitamin A deficiency increased the serum glucose
in VAM group from the zero to the second generations (P<0.001).
Meanwhile serum glucose in VAM and recovery groups were
increased significantly compared to VAS group (P<0.005) and a
negative significant correlation observed between retinol and se-
rum glucose in the first (R=0.66, P<0.005) and the second gen-
erations (R=0.74, P<0.0001)
Conclusion: These data suggest that chronic marginal vita-
min A deficiency deteriorate growth and metabolic indices in rat
and these detrimental effects will be intensified when they are
transferred to the next generations.
Key words: Vitamin A deficiency, gestation, growth index,
metabolic indices, and rat
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SURGICAL INTERVENTION IN INFLAMMATORY BOWEL
DISEASE (IBD)
I D Sugarman, Consultant Paediatric Surgeon,
Leeds General Infirmary, Leeds, UK
As the incidence of IBD in children increases so does the
requirement of surgical intervention. This presentation will give a
brief overview of surgery in IBD. This will cover the different pro-
cedures in Crohn’s disease and how this is related to the site
affected (isolated small bowel disease, ileocaecal disease, co-
lonic and anal disease), colectomy and either ileorectal anasto-
mosis or ileal pouch anal anastomosis (IPAA) in ulcerative colitis
and the problems that occur with these procedures. The presen-
tation will cover the problems of IPAA procedure when the diag-
nosis is either ‘indeterminate’ or Crohn’s colitis. Finally, the pre-
sentation will cover the use and problems with stoma’s (ileostomy
or colostomy) in children with IBD.
References: Keighley MRB and Williams NS. Surgery of the
anus, rectum and colon. 2nd edition. 1999. WB Saunders London
UK (This is the authorative textbook on surgery in IBD)
Stringer MD et al. Paediatric surgery and urology: long term
outcomes. 1st edition.
WB Saunders London UK Chapter 27 (This gives the surgery
and outcome from the childs perspective)
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NUTRITIONAL MANAGEMENT OF FAILURE TO THRIVE
(FTT) IN DEVELOPING COUNTRIES: SOUTH AFRICA &
AFRICA:
Marcha Venter, MSc Nutr. & Diet.
Red Cross Children’s Hospital, Cape Town, South Africa
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Background: The treatment of FTT in SA and Africa, from its
mildest form, malnutrition, to its most severe form, Kwashiorkor &
Marasmus, is part & parcel of most health professional’s day.
Poverty and HIV/AIDS significantly adds to the dilemma. The
prevalence of HIV world wide is 41 million (01); 28,1 million in
Sub-Saharan Africa (01), and 5 million in SA. That is 25% of the
SA population, with ± 250 000 <15 yrs old (01).
Despite the fact that South Africa is relatively wealthy in com-
parison to the rest of Africa, a prevalence of 50% of the total SA
population are classified as: Poor (Survive on <R1500/mnth
(±150 Euro) for a family of 2 adults & 2 children).
The SAVACG (95) study found that 23% (1 in 4) children in
SA were stunted (reflection of SES), 9% (1 in 10) children in SA
were underweight, 33% (1 in 3) children had marginal Vitamin A
status, and 1 in 5 children was anaemic.
All stats included, are the latest trustworthy figures available.
Classification:
1. Malnutrition-FTT: ↓ in wt centiles  2 consecutive
months, No gain in ht  2 consecutive months (same wt) and a
plato in weight / height gain  2 consecutive months
2. Marasmus: According to the ‘Wellcome Trust Classifica-
tion (WTC): <60% expected wt for age, with no oedema present.
Clinical: Severe PEM, extreme weight loss, weakness.
3. Kwashiorkor: According to ‘WTC: 60–80% of expected wt
for age, with oedema present. Clinical: Hypoalbuminemia, Anae-
mia, Oedema, Pot belly, Depigmented skin, Hair is soft-brittle-
sparse-reddish colour, undigested food in stools, liver is often
fatty infiltrated
4. Marasmic-Kwashiorkor: According to ‘WTC: <60% ex-
pected wt for age with / without oedema present.
Treatment: There is a SA Protein-Energy-Malnutrition
Supplementation Programme ‘NSP’ that is operating from a
community-clinic basis. Specific entry – and exit criteria has been
laid down re. above discussed conditions, as well as for
HIV/AIDS and breastfeeding mothers. The scheme provide an
infant formula Nan-Pelargon, enriched porridge and a High En-
ergy Drink, 1 yr +.
An important aspect of consulting with these cases, is also
that of disease detection. An initial referral of malnutrition could
more than often include HIV, TB, parasites / worms, FAS and
mild to severe anaemia.
A very important aspect to keep in consideration when treat-
ing the cases mentioned in 1–4, is the dangers of the Refeeding
Syndrome. During starvation fat and especially muscle stores
(incl. the heart muscle) is the main source of fuel due to severe
catabolism. During refeeding, carbohydrates become the main
fuel source, which results in Insulin release, and enhanced up-
take of Glucose, PO4, K and water into cells. This could lead to
GIT, Cardiopulmonary and Renal complications. Ileus, villi atro-
phy, polyuria, arythmias, Congestive Heart Failure and death, are
some of these complications.
Conclusion: The treatment of malnutrition, poverty, TB and
HIV/AIDS are continual elaborate challenges for the government
and health professionals in SA and Africa. How do we solve the
problem? Treat them one by one – ‘Mother Theresa.’
References: 1. Eley BS, Sive A, Abelse L. Growth and mi-
cronutrient disturbances in stable HIV-infected children in Cape
Town. Ann of Tropical Paed 2002; 22, 19–23
2. Solomon SM, Kirby DF. The Refeeding Syndrome: A Re-
view. JPEN 1990; (14) 1, 90–97
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Nutritional Treatment of Bilairy Atresia Patients:Pre-& Post
Liver Transplant
Marcha Venter, MSc, Nutr. & Diet.
Red Cross Children’s Hospital, Cape Town, South Africa
Background: Red Cross Children’s Hospital (RXH), Cape
Town, South Africa is the only dedicated children’s hospital in
SubSaharan Africa. It is also the only unit in Africa that does
children’s liver transplants between birth & 13 yrs old. Limited
resources and organ donors, is the main reason why RXH has
only performed 80 livertransplants over the last 20 years. These
patients where mainly diagnosed with Bilairy Atresia and Hepa-
titis A. Living-related transplants only started in 2002. However,
RXH remains a bright light of hope for Africa and SA.
Treatment:
1. Infant & Toddler Feeding: Breast is Best (lipase, DHA, AA
etc.)
• Breast is Best! (Lipase, DHA, EPA , AA etc.).
Energy - 160 kcal/kg/day, Glucose polymer - ↑ in 2%
increments as tolerated until requirements are reached.
MCT oil - ↑ in 0.5% increments, as tolerated until re-
quirements are reached. Fat:CHO ratio 40:60. Protein
4g/kg/day or [12–15% of total energy]. Modular/Hy-
drolysed Whey Protein - ↑ in increments maintaining
total protein ratio at 9 - 12% of total energy. Volume:
150 – 180 ml/kg
• Alternative feeding: Polymeric Infant feed with MCT’s
[palatable, available, cost], or, Semi-elemental Infant
formulae
• Optimal Neurological & Visual Development: Formu-
lae should contain / or be supplemented with: Docsa-
hexaenoic Acid (DHA), Eicosapentaenoic acid (EPA) &
Arachidonic Acid (AA)
• BCAA: Controversial: Preferentially used in catabolism
to spare bodily prot. stores. Goal: Provide enough prot.,
without further liver deterioration & ↓ Risk of encepha-
lopathy (protect brain).
• Weaning: As any other infant only supplements could
also now be added to the food.
• Vitamins & Minerals: Monitor Serum levels regularly
(not always practical).
a. Vitamin K: On diagnosis – 1 mg IV, no improvement,
continued & gradually changed to oral prep: 5–10 mg
tablets wkly
b. Vitamin D: On diagnosis, 30 000 - 60 000i.u. repeated
monthly for 3 months
c. Vitamin E: A single IM dose of 10mg/kg post opp - then
15mg - 200mg/kg/day orally
d. Iron: Therapeutic dose of oral iron, when deficiency is
seen.
e. Zinc: 1mg/kg/d
2. The older child:
• From 10/12 to 1 yr +: Breast & or/ Polymeric Enteral
Feed with MCT’s
• Consider: Over night Pump-infused NG feeds
• Supplementation continues: MCT’s, Protein, Glucose
polymer
• Energy: 120–150% of RDA, Protein: 12–15 % of total
energy
3. Nutritional Assessment:
• Serial measurements, Weight (Poor marker, oe-
dema), Length, Head circumference, Skinfold thick-
nesses: supra-ileac often too painful / impossible to
do accurately, Abdominal girth, Biochemical mark-
ers
4. Ascites:
• Fluid restriction, often: 80 – 100 ml/kg, Fully supple-
mented feeds: 1.6 – 2 kcal/ml
5. Oesophageal Varices:
• Banding / Sclerotherapy: Clear fluids 12 – 24 hrs post
Rx, Soft diet 1wk +
6. Hepatic encephalopathy:
• Prot. restriction relative to degree of encephalopathy
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• Grade 3/4 encephalopathy: NG feed, enough energy,
minimum protein 0.5g/kg, intake in 0.5g/kg increments
as improve
7. Liver Transplant:
• Fat Free TPN: First day/ 2, rarely more
• Start enteral feeding NGT / Oral a.s.a.p., usually day
2–3
• Extubated, stable: Diet appropriate for age
• F/up: Maintain good nutritional status
Conclusion: We thank a dedicated team of health profes-
sionals for fighting to maintain the only dedicated paediatric liver
transplant unit in Sub-Saharan Africa.
References:
1. Otte JB. History of pediatric liver transplantation. Where are
we coming from? Where do we stand? Pediatr Transplant. 2002
Oct; 6 (5): 378–87
2. The Liver and Pancreas. In: Clinical Paediatrics Dietetic-
s.(Ed) Shaw V, Lawson M. Blackwell Publishing, 2001; 110–136.
ANSWERS/DISCUSSIONS
Clinical Quiz, continued from page 211
Answer: The patient underwent oesophagectomy with gastric interposition and pyloromyotomy. The
biopsy result confirmed the diagnosis of oesophageal leiomyomatosis with irregular fragments of smooth
muscle with associated fibrous tissue, blood vessels and nerve trunks. Currently, she is completely
asymptomatic and is on full enteral feeds. She is gaining weight satisfactorily and is happy with her life.
Leiomyomatosis of the oesophagus is extremely rare condition in children (1). It should be distin-
guished from oesophageal leiomyoma, which is a localised capsulated benign lesion1. Only 33 paediatric
cases less than 18 years of age (including our case) have been reported in the literature (2–6). Clinical
manifestations include vomiting, regurgitation, dysphagia, anorexia, cough, dyspnoea and/or cyanosis
when swallowing, choking, hiccups, recurrent pneumonia, stridor and apnoea, faltering growth and
weight loss and retrosternal pain. Haematemesis can occasionally occur as a clinical expression of
oesophagitis (1–6). Other manifestations like haematuria and constipation are usually related to its
association with Alport syndrome and leiomyomatosis at other sites (3–4).
Hall published the first report of a presumable oesophageal leiomyomatosis in 1916 (7). In 1983,
Garcia-Torres and Gaurner first described an association of oesophageal leiomyomatosis and haematuric
glomerular nephritis as a distinct clinical variant of Alport syndrome (haematuria, nephritis, sensorineural
deafness and congenital cataract) (8). Since then, a number of cases have been reported, and a new term
was coined: Alport Leiomyomatosis syndrome (1).
The diagnostic work up includes a detailed history and examination. Chest x-ray usually shows a wide
mediastinum or a right-sided mediastinal mass. Diagnosis by barium studies and/or endoscopy is difficult
as overlying mucosa remains intact. A thoracic CT or MRI scan is helpful but not diagnostic (5).
Similarly, oesophageal manometry is also of little help in confirming the diagnosis. Endoscopic ultra-
sonography is described as a useful investigation by some authors (5).
The treatment is surgical. The affected oesophagus and gastric fundus, when involved, are resected and
replaced with a gastric tube or colonic segment (1–6). Usually, a pyloromyotomy is also performed due
to its association with pyloric stenosis. Outcome is good with disappearance of symptoms following
surgery. No cases of relapse have been described untill now in children after resection of the affected
oesophagus for diffuse leiomyomatosis (1–6).
REFERENCES
1. Federici S, Ceccarelli PL, Bernardi F, et al. Esophageal leiomyomatosis in children: report of a case
and review of the literature. Eur J Pediatr Surg 1998;8:358–63.
2. Lee H, Morgan K, Abramowsky C, Ricketts RR. Leiomyoma at the site of esophageal atresia repair.
J Pediatr Surg 2001;36:1832–3.
3. Lerone M, Doredo P, Romeo G, et al. Leiomyomatosis od oesophagus, congenital cataracts and
hematuria: report of a case with rectal involvement. Pediatr Radiol 1991;21:578–9.
4. Lonsdale RN, Roberts PF, Vaughan R, Thiru S. Familial oesophageal leiomyomatosis and nephrop-
athy. Histopathology 1992;20:127–33.
5. Massicot R, Aubert D, Mboyo A, Destuynder O, Queneau PE. Localised esophageal leiomyoma and
hypertrophic osteoarthropathy. J Pediatr Surg 1997;32:646–7.
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